Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
MedMen financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
$0
2024-05-15
Market Capitalization
$20.7 M
2024-05-15
Revenue
$140.8 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 |
|---|---|---|
| Revenue | 145.1M | 140.8M |
| Cost of goods sold | 2.7M | 1.6M |
| Gross profit | 67.3M | 69.7M |
| Gross profit margin, % | 49.5% | |
| General and administrative expense | 124.6M | 108.7M |
| Operating expense total | 134.9M | 238.7M |
| Depreciation and amortization | 31.1M | |
| EBIT | (67.6M) | (168.9M) |
| EBIT margin, % | -120.0% | |
| Investment income | (649.2K) | (91.6K) |
| Interest expense | 36.6M | 32.4M |
| Pre tax profit | (145.4M) | (165.6M) |
| Income tax expense | 1.8M | (9.9M) |
| Net Income | 210.9M |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |